Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
US-12590168-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Olson Kara patents
Olson Kara is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Olson Kara |
| Total patents | 19 |
| First publication | Jan 23, 2020 |
| Latest publication | Mar 31, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
GPRC5D x CD28 Bispecific Antibodies and Methods of Use Thereof
US-2026014252-A1 · Jan 15, 2026 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2026008862-A1 · Jan 8, 2026 · US
Compositions and methods for treating cytokine release syndrome
US-2025302949-A1 · Oct 2, 2025 · US
Bispecific anti-cd28 x anti-cd22 antibodies and uses thereof
US-2025223360-A1 · Jul 10, 2025 · US
Compositions and methods for treating cytokine release syndrome
US-12274747-B2 · Apr 15, 2025 · US
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies
US-12258412-B2 · Mar 25, 2025 · US
Antigen-binding molecules that bind cd38 and/or cd28, and uses thereof
US-2024158529-A1 · May 16, 2024 · US
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
US-11905332-B2 · Feb 20, 2024 · US
Multispecific antigen binding molecules that bind cd38 and 4-1bb, and uses thereof
US-2023416396-A1 · Dec 28, 2023 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for universal tumor cell killing
US-2023357446-A1 · Nov 9, 2023 · US
Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof
US-2023174652-A1 · Jun 8, 2023 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2022306758-A1 · Sep 29, 2022 · US
Compositions and methods for treating cytokine release syndrome
US-2022233690-A1 · Jul 28, 2022 · US
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
US-11396544-B2 · Jul 26, 2022 · US
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
US-11384153-B2 · Jul 12, 2022 · US
Antigen-binding molecules that bind cd38 and/or cd28, and uses thereof
US-2022089766-A1 · Mar 24, 2022 · US
Bispecific anti-cd28 x anti-cd22 antibodies and uses thereof
US-2020239576-A1 · Jul 30, 2020 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2020024356-A1 · Jan 23, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 19 |
| Regeneran Pharmaceuticals Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 19 |
| C07K2317/31 | 19 |
| C07K16/2809 | 18 |
| A61K2039/505 | 18 |
| C07K16/2818 | 16 |